Tapewire

Nasdaq · USD

ICCM

IceCure Medical Ltd.

Export transactions ↓
Tapewire entity
8100
SEC CIK
0001584371
Parsed reports
22

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 14, 2026 Filed Aug 17, 2026 12:26 UTC
Good ShadVP, Sales for North America
GrantOrdinary Shares 131,483 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-090515 · ownership.xml · nonDerivative · entry 1

Good Shad · CIK 0002047216 · VP, Sales for North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,698

F1 · balance_after: Represents (i) 131,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 219 ordinary shares, (iii) 2,021 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,757 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 1,218 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 12:16 UTC
Levav ShayChief Operating Officer
GrantOrdinary Shares 141,483 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-090509 · ownership.xml · nonDerivative · entry 1

Levav Shay · CIK 0002047217 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,303

F1 · balance_after: Represents (i) 141,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 2,727 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iii) 1,447 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (iv) 646 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clauses (ii) through (iv) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 12:17 UTC
Tel-Tzure Tlalit BussiVP, BD & Global Marketing
GrantOrdinary Shares 101,483 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-090510 · ownership.xml · nonDerivative · entry 1

Tel-Tzure Tlalit Bussi · CIK 0002040298 · VP, BD & Global Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,518

F1 · balance_after: Represents (i) 101,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 653 ordinary shares, (iii) 2,273 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,733 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 1,029 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 12:16 UTC
Dotan Merav NirVP, Human Resources
GrantOrdinary Shares 73,890 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-090508 · ownership.xml · nonDerivative · entry 1

Dotan Merav Nir · CIK 0002048789 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,168

F1 · balance_after: Represents (i) 73,890 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 17 ordinary shares, (iii) 758 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,080 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 440 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 12:15 UTC
Peleg MeirChief Financial Officer
GrantOrdinary Shares 181,483 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-090507 · ownership.xml · nonDerivative · entry 1

Peleg Meir · CIK 0002131274 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,816

F1 · balance_after: Represents (i) 181,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, and (ii) 13,333 RSUs granted on May 17, 2026, 25% of which vest on May 17, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter. All of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clause (ii) has been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.